Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOKITO-2B: Tenofovir DF Bone and Kidney Toxicity in Chronic Hepatitis B
2011-004272-11Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (3 arms), sponsored by Erasmus MC. Primary endpoint: Prevalence and incidence of renal insufficiency and kidney proximal tubular dysfunction. Started Oct 2011; status: active.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2011-004272-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004272-11.